Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mFOLFOX6”

150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 150 results

Large-scale testing (Phase 3)Study completedNCT03511963
What this trial is testing

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai Henlius Biotech 677
Large-scale testing (Phase 3)Ended earlyNCT04034355
What this trial is testing

Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer

Who this might be right for
Colorectal CancerChemotherapy-induced Peripheral Neuropathy
Egetis Therapeutics 301
Testing effectiveness (Phase 2)UnknownNCT05480280
What this trial is testing

MFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Advanced/Metastatic Colorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 18
Testing effectiveness (Phase 2)Ended earlyNCT00209703
What this trial is testing

Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group 30
Early research (Phase 1)Ended earlyNCT03176264
What this trial is testing

PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Novartis Pharmaceuticals 1
Large-scale testing (Phase 3)UnknownNCT02402972
What this trial is testing

A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

Who this might be right for
Colorectal CancerMetastasis
Xu jianmin 700
Large-scale testing (Phase 3)Study completedNCT02394795
What this trial is testing

Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC

Who this might be right for
Colorectal Cancer
Takeda 823
Large-scale testing (Phase 3)Temporarily pausedNCT00316745
What this trial is testing

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group 200
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Large-scale testing (Phase 3)UnknownNCT01092481
What this trial is testing

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Who this might be right for
Colon Cancer
Samsung Medical Center 1,580
Testing effectiveness (Phase 2)Study completedNCT00308516
What this trial is testing

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Who this might be right for
Rectal CancerCancer of the RectumColorectal Cancer
SCRI Development Innovations, LLC 66
Early research (Phase 1)Looking for participantsNCT05365581
What this trial is testing

ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 398
Not applicableAvailableNCT06048081
What this trial is testing

Early Access Program for Zolbetuximab

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma CancerLocally Advanced Unresectable Gastric Adenocarcinoma CancerMetastatic Gastric Adenocarcinoma Cancer+1 more
Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Study completedNCT03043729
What this trial is testing

MFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer

Who this might be right for
Rectal CancerRectosigmoid Cancer
AIO-Studien-gGmbH 119
Testing effectiveness (Phase 2)Study completedNCT00321828
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
NSABP Foundation Inc 90
Large-scale testing (Phase 3)Study completedNCT03231722
What this trial is testing

First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 435
Testing effectiveness (Phase 2)Ended earlyNCT03547999
What this trial is testing

A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC

Who this might be right for
Metastatic Colorectal Cancer
Patrick Boland 17
Large-scale testing (Phase 3)Enrolling By InvitationNCT05179889
What this trial is testing

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Who this might be right for
Colon Cancer Stage III
Chungnam National University Hospital 308
Testing effectiveness (Phase 2)UnknownNCT01529164
What this trial is testing

Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Chinese Academy of Medical Sciences 51
Testing effectiveness (Phase 2)Looking for participantsNCT06002789
What this trial is testing

Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC

Who this might be right for
Multiple CancerColorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 17
Load More Results